ProPhase Labs, Inc.
PRPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $2 | $9 | $9 |
| Short-Term Investments | $0 | $3 | $8 | $9 |
| Receivables | $20 | $36 | $37 | $38 |
| Inventory | $1 | $2 | $4 | $5 |
| Other Curr. Assets | $9 | $5 | $2 | $1 |
| Total Curr. Assets | $31 | $48 | $61 | $61 |
| Property Plant & Equip (Net) | $12 | $15 | $11 | $10 |
| Goodwill | $5 | $5 | $6 | $6 |
| Intangibles | $10 | $12 | $8 | $11 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $7 | $0 | $0 |
| Other NC Assets | $6 | $5 | $1 | $1 |
| Total NC Assets | $33 | $44 | $27 | $28 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $63 | $92 | $88 | $89 |
| Liabilities | – | – | – | – |
| Payables | $14 | $9 | $6 | $7 |
| Short-Term Debt | $7 | $3 | $0 | $1 |
| Tax Payable | $2 | $3 | $4 | $1 |
| Deferred Revenue | $2 | $2 | $2 | $2 |
| Other Curr. Liab. | $8 | $4 | $3 | $4 |
| Total Curr. Liab. | $32 | $21 | $16 | $16 |
| LT Debt | $18 | $16 | $7 | $14 |
| Deferred Rev, NC | $1 | $1 | $1 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $5 | $5 | $0 | $0 |
| Total NC Liab. | $24 | $22 | $8 | $15 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $6 | $8 | $4 | $4 |
| Total Liabilities | $56 | $43 | $24 | $31 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$58 | -$5 | $12 | $3 |
| AOCI | -$0 | -$0 | $1 | -$0 |
| Other Equity | $66 | $55 | $51 | $56 |
| Total Equity | $7 | $49 | $64 | $59 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $63 | $92 | $88 | $89 |
| Net Debt | $24 | $17 | -$2 | $6 |